Back
ProShares MSCI EAFE Dividend Growers ETF Vs. Summit Therapeutics Industry Stock Comparison
Buy
64
EFAD
ProShares MSCI EAFE Dividend Growers ETF
Last Price:
$42.12
Seasonality Move:
1.19%
Sell
37
SMMT
Summit Therapeutics
Last Price:
$21.24
Seasonality Move:
19.62%
Buy
64
ProShares MSCI EAFE Dividend Growers ETF (EFAD)
is a Buy
Is ProShares MSCI EAFE Dividend Growers ETF a Buy, Sell or Hold?
-
The current ProShares MSCI EAFE Dividend Growers ETF [EFAD] share price is $42.79. The Score for EFAD is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
-
EFAD is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
37
Summit Therapeutics (SMMT)
is a Sell
Is Summit Therapeutics a Buy, Sell or Hold?
-
The current Summit Therapeutics [SMMT] share price is $20.92. The Score for SMMT is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
-
SMMT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
EFAD Stock Price Chart
What is ProShares MSCI EAFE Dividend Growers ETF's stock price today?
-
The ProShares MSCI EAFE Dividend Growers ETF share price today is $42.79The current trend is moderately bearish and EFAD is experiencing slight buying pressure.
SMMT Stock Price Chart
What is Summit Therapeutics's stock price today?
-
The Summit Therapeutics share price today is $20.92The current trend is relatively stagnant and SMMT is experiencing slight selling pressure.
EFAD Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.52 | Buy |
| Relative Strength Index (14 RSI): | 57.83 | Buy |
| Chaikin Money Flow: | 372 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (42.01 - 42.91) | Buy |
| Bollinger Bands (100): | (38.46 - 41.86) | Buy |
SMMT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.84 | Sell |
| Relative Strength Index (14 RSI): | 47.51 | Sell |
| Chaikin Money Flow: | -1063174 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (19.13 - 24.45) | Sell |
| Bollinger Bands (100): | (18.58 - 25.02) | Sell |
EFAD Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 42.61 | Buy |
| 20-day SMA: | 42.61 | Buy |
| 50-day SMA: | 41.55 | Buy |
| 200-day SMA: | 39.71 | Buy |
| 8-day EMA: | 42.55 | Buy |
| 20-day EMA: | 42.37 | Buy |
| 50-day EMA: | 38.82 | Buy |
| 200-day EMA: | 19.85 | Buy |
SMMT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 20.22 | Buy |
| 20-day SMA: | 20.97 | Sell |
| 50-day SMA: | 23.63 | Sell |
| 200-day SMA: | 20.82 | Buy |
| 8-day EMA: | 20.47 | Buy |
| 20-day EMA: | 21.13 | Sell |
| 50-day EMA: | 21.99 | Sell |
| 200-day EMA: | 19.36 | Buy |
ProShares MSCI EAFE Dividend Growers ETF Earnings Growth & EFAD Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Summit Therapeutics Earnings Growth & SMMT Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.02 per share, a decrease next quarter of $0.01 per share, a decrease this year of $0.10 per share, and a decrease next year of $0.11 per share.
ProShares MSCI EAFE Dividend Growers ETF Technical Analysis
| Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 16 | Jun 17 | Jun 18 | Jun 20 | Jun 23 | Jun 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 10 | 11 | 12 | 13 | 16 | 17 | 18 | 20 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Summit Therapeutics Technical Analysis
| Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 16 | Jun 17 | Jun 18 | Jun 20 | Jun 23 | Jun 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 10 | 11 | 12 | 13 | 16 | 17 | 18 | 20 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||